These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

438 related items for PubMed ID: 17693666

  • 1. Single-nucleotide polymorphisms at the TP53-binding or responsive promoter regions of BAX and BCL2 genes and risk of squamous cell carcinoma of the head and neck.
    Chen K, Hu Z, Wang LE, Sturgis EM, El-Naggar AK, Zhang W, Wei Q.
    Carcinogenesis; 2007 Sep; 28(9):2008-12. PubMed ID: 17693666
    [Abstract] [Full Text] [Related]

  • 2. Genetic polymorphisms of p21 are associated with risk of squamous cell carcinoma of the head and neck.
    Li G, Liu Z, Sturgis EM, Shi Q, Chamberlain RM, Spitz MR, Wei Q.
    Carcinogenesis; 2005 Sep; 26(9):1596-602. PubMed ID: 15878916
    [Abstract] [Full Text] [Related]

  • 3. Polymorphisms of FAS and FAS ligand genes involved in the death pathway and risk and progression of squamous cell carcinoma of the head and neck.
    Zhang Z, Wang LE, Sturgis EM, El-Naggar AK, Hong WK, Amos CI, Spitz MR, Wei Q.
    Clin Cancer Res; 2006 Sep 15; 12(18):5596-602. PubMed ID: 17000697
    [Abstract] [Full Text] [Related]

  • 4. 172G>T variant in the 5' untranslated region of DNA repair gene RAD51 reduces risk of squamous cell carcinoma of the head and neck and interacts with a P53 codon 72 variant.
    Lu J, Wang LE, Xiong P, Sturgis EM, Spitz MR, Wei Q.
    Carcinogenesis; 2007 May 15; 28(5):988-94. PubMed ID: 17118968
    [Abstract] [Full Text] [Related]

  • 5. Association between the V109G polymorphism of the p27 gene and the risk and progression of oral squamous cell carcinoma.
    Li G, Sturgis EM, Wang LE, Chamberlain RM, Spitz MR, El-Naggar AK, Hong WK, Wei Q.
    Clin Cancer Res; 2004 Jun 15; 10(12 Pt 1):3996-4002. PubMed ID: 15217930
    [Abstract] [Full Text] [Related]

  • 6. Potentially functional single nucleotide polymorphisms in the core nucleotide excision repair genes and risk of squamous cell carcinoma of the head and neck.
    An J, Liu Z, Hu Z, Li G, Wang LE, Sturgis EM, El-Naggar AK, Spitz MR, Wei Q.
    Cancer Epidemiol Biomarkers Prev; 2007 Aug 15; 16(8):1633-8. PubMed ID: 17684138
    [Abstract] [Full Text] [Related]

  • 7. Haplotypes of two variants in p16 (CDKN2/MTS-1/INK4a) exon 3 and risk of squamous cell carcinoma of the head and neck: a case-control study.
    Zheng Y, Shen H, Sturgis EM, Wang LE, Shete S, Spitz MR, Wei Q.
    Cancer Epidemiol Biomarkers Prev; 2002 Jul 15; 11(7):640-5. PubMed ID: 12101111
    [Abstract] [Full Text] [Related]

  • 8. p53 codon 72 polymorphism associated with risk of human papillomavirus-associated squamous cell carcinoma of the oropharynx in never-smokers.
    Ji X, Neumann AS, Sturgis EM, Adler-Storthz K, Dahlstrom KR, Schiller JT, Wei Q, Li G.
    Carcinogenesis; 2008 Apr 15; 29(4):875-9. PubMed ID: 18258602
    [Abstract] [Full Text] [Related]

  • 9. Thymidylate synthase 5'- and 3'-untranslated region polymorphisms associated with risk and progression of squamous cell carcinoma of the head and neck.
    Zhang Z, Shi Q, Sturgis EM, Spitz MR, Hong WK, Wei Q.
    Clin Cancer Res; 2004 Dec 01; 10(23):7903-10. PubMed ID: 15585623
    [Abstract] [Full Text] [Related]

  • 10. The role of genetic polymorphisms in the promoters of the matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 genes in head and neck cancer.
    O-Charoenrat P, Khantapura P.
    Oral Oncol; 2006 Mar 01; 42(3):257-67. PubMed ID: 16275157
    [Abstract] [Full Text] [Related]

  • 11. Elevated risk of squamous-cell carcinoma of the lung in heavy smokers carrying the variant alleles of the TP53 Arg72Pro and p21 Ser31Arg polymorphisms.
    Popanda O, Edler L, Waas P, Schattenberg T, Butkiewicz D, Muley T, Dienemann H, Risch A, Bartsch H, Schmezer P.
    Lung Cancer; 2007 Jan 01; 55(1):25-34. PubMed ID: 17059853
    [Abstract] [Full Text] [Related]

  • 12. p53 mutations and p53, Waf-1, Bax and Bcl-2 expression in field cancerization of the head and neck.
    Lavieille JP, Gazzeri S, Riva C, Reyt E, Brambilla C, Brambilla E.
    Anticancer Res; 1998 Jan 01; 18(6B):4741-9. PubMed ID: 9891551
    [Abstract] [Full Text] [Related]

  • 13. p53 apoptotic response to DNA damage dependent on bcl2 but not bax in head and neck squamous cell carcinoma lines.
    Crowe DL, Sinha UK.
    Head Neck; 2006 Jan 01; 28(1):15-23. PubMed ID: 16302195
    [Abstract] [Full Text] [Related]

  • 14. Single-nucleotide polymorphisms in DNA double-strand break repair genes: association with head and neck cancer and interaction with tobacco use and alcohol consumption.
    Werbrouck J, De Ruyck K, Duprez F, Van Eijkeren M, Rietzschel E, Bekaert S, Vral A, De Neve W, Thierens H.
    Mutat Res; 2008 Oct 30; 656(1-2):74-81. PubMed ID: 18768166
    [Abstract] [Full Text] [Related]

  • 15. Role of BCL2 (ala43thr), CCND1 (G870A) and FAS (A-670G) polymorphisms in modulating the risk of developing esophageal cancer.
    Jain M, Kumar S, Lal P, Tiwari A, Ghoshal UC, Mittal B.
    Cancer Detect Prev; 2007 Oct 30; 31(3):225-32. PubMed ID: 17561354
    [Abstract] [Full Text] [Related]

  • 16. p53 codon 72 polymorphic variants, loss of allele-specific transcription, and human papilloma virus 16 and/or 18 E6 messenger RNA expression in squamous cell carcinomas of the head and neck.
    Scheckenbach K, Lieven O, Götte K, Bockmühl U, Zotz R, Bier H, Balz V.
    Cancer Epidemiol Biomarkers Prev; 2004 Nov 30; 13(11 Pt 1):1805-9. PubMed ID: 15533911
    [Abstract] [Full Text] [Related]

  • 17. Analysis of human papillomavirus prevalence and TP53 polymorphism in head and neck squamous cell carcinomas.
    Cortezzi SS, Provazzi PJ, Sobrinho JS, Mann-Prado JC, Reis PM, de Freitas SE, Filho JF, Fukuyama EE, Cordeiro JA, Cury PM, Maniglia JV, Villa LL, Tajara EH, Rahal P.
    Cancer Genet Cytogenet; 2004 Apr 01; 150(1):44-9. PubMed ID: 15041222
    [Abstract] [Full Text] [Related]

  • 18. Single nucleotide polymorphisms in MMP1 and MMP3 gene promoters as risk factor in head and neck squamous cell carcinoma.
    Zinzindohoué F, Blons H, Hans S, Loriot MA, Houllier AM, Brasnu D, Laccourreye O, Tregouet DA, Stucker I, Laurent-Puig P.
    Anticancer Res; 2004 Apr 01; 24(3b):2021-6. PubMed ID: 15274394
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Caspase 9 promoter polymorphisms and risk of primary lung cancer.
    Park JY, Park JM, Jang JS, Choi JE, Kim KM, Cha SI, Kim CH, Kang YM, Lee WK, Kam S, Park RW, Kim IS, Lee JT, Jung TH.
    Hum Mol Genet; 2006 Jun 15; 15(12):1963-71. PubMed ID: 16687442
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.